In Alagille syndrome…
AIM TO DITCH THE ITCH
Once-daily LIVMARLI is the first and only FDA-approved medicine for cholestatic pruritus (itch) in patients with Alagille syndrome who are 1 year of age and older.
Financial support options that may help with out-of-pocket costs for LIVMARLI are available.Find Out More
In a clinical study, many patients taking LIVMARLI experienced significantly less itchiness.See the Results
WELCOME TO THE LIVER LEAGUE INFORMATION BOOTH
Stay in the Know
To receive more information about LIVMARLI as it becomes available, please fill out the form below.
Your sign-up was successful!
Be on the lookout for a welcome email from Mirum soon. Make sure to add email@example.com to your address book so that our emails go directly to your inbox.
We're having some connection trouble.
Refresh the page and try submitting your form again.
Note: This issue may occur if your email is already registered. Please check your inbox and spam folder to make sure you're receiving information. If the issue persists, please contact us.
Looks like this email is already registered.
Please check your inbox and spam folder to make sure you're receiving information.